(Q36267709)

English

Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure (English)

1 reference

Europe PubMed Central

13 August 2017

0 references

0 references

2

object named as

Eric Boersma

1 reference

Europe PubMed Central

13 August 2017

Maarten L Simoons

9

object named as

Maarten L Simoons

1 reference

Europe PubMed Central

13 August 2017

5

object named as

Michel Komajda

1 reference

Europe PubMed Central

13 August 2017

6

object named as

Karl Swedberg

1 reference

Europe PubMed Central

13 August 2017

author name string

Mattie J Lenzen

1

1 reference

Europe PubMed Central

13 August 2017

Wilma J M Scholte Op Reimer

3

1 reference

Europe PubMed Central

13 August 2017

Aggie H M M Balk

4

1 reference

Europe PubMed Central

13 August 2017

Ferenc Follath

7

1 reference

Europe PubMed Central

13 August 2017

Manuel Jimenez-Navarro

8

1 reference

Europe PubMed Central

13 August 2017

John G F Cleland

10

1 reference

Europe PubMed Central

13 August 2017

publication date

23 September 2005

1 reference

Europe PubMed Central

13 August 2017

European Heart Journal

1 reference

Europe PubMed Central

13 August 2017

26

1 reference

Europe PubMed Central

13 August 2017

24

1 reference

Europe PubMed Central

13 August 2017

2706-2713

1 reference

Europe PubMed Central

13 August 2017

The epidemiology of heart failure: the Framingham Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Survival of patients with a new diagnosis of heart failure: a population based study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Heart failure in a district general hospital: are target doses of beta-blockers realistic?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Clinical trials and the real world: selection bias and generalisability of trial results.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Angiotensin converting enzyme inhibition in heart failure: clinical trials and clinical practice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Bisoprolol dose-response relationship in patients with congestive heart failure: a subgroup analysis in the cardiac insufficiency bisoprolol study(CIBIS II).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI499

21 January 2018

Why don't physicians follow clinical practice guidelines? A framework for improvement

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1001/JAMA.282.15.1458

Identifiers

10.1093/EURHEARTJ/EHI499

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36267709&oldid=1649681593"